BACKGROUND
Osteoporosis is characterised by low bone mass and structural
deterioration of bone tissue, with a consequent increase in
susceptibility to fragility fracture. Fractures cause significant pain,
disability and loss of independence and can be fatal.
[1]
OBJECTIVE
To assess the relative efficacy of bisphosphonates (alendronate,
risedronate, ibandronate and zoledronate) for the treatment of
Osteoporosis using a network meta-analysis (NMA).
History
Ethics
There is no personal data or any that requires ethical approval
Policy
The data complies with the institution and funders' policies on access and sharing